Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
FMS · against 1,372 other Healthcare companies
Ranked #1,085 of 1,373 · scores higher than 21% of peers · safety percentile 21
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 20–29, including FMS · Click a bar to see the companies
Mainly because of its current ratio, debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | FMS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.81× | 0.24× | 19% | 33% | |
| BetaLower is better · 1,320 reported | 0.83 | 0.53 | 33% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.07× | 2.62× | 12% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,081 | 5.9B USD | 21 | 39 | |
| 1,082 | 540.4B BRL (≈$97.3B) | 21 | 64 | |
| 1,082 | 162.93T ARS (≈$162.9B) | 21 | 63 | |
| 1,084 | 4.3B CNY (≈$608M) | 21 | 20 | |
| 1,085 | 11.6B USD | 21 | 58 | |
| 1,086 | 10.4B USD | 21 | 64 | |
| 1,087 | 10.8B USD | 21 | 35 | |
| 1,088 | 3.1B USD | 21 | 46 | |
| 1,089 | 45.9B USD | 21 | 61 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score